The Hydroxyzine Hydrochloride Tablet, cataloged under National Stock Number 6505-01-530-3334, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Kvk-Tech Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-530-3334 |
| Primary Part Number | NDC10702-0011-01 |
| Item Name | Hydroxyzine Hydrochloride Tablet |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Kvk-Tech Inc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| American Hospital Formulary Service Classification Number | 282492 |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC10702-0011-01 PRIMARY | Kvk-Tech Inc (USA) |
| NDC00093-5061-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 05-0874 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-530-3334 is a Hydroxyzine Hydrochloride Tablet, manufactured by Kvk-Tech Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-530-3334 has 2 manufacturer part numbers on file: NDC10702-0011-01 (Kvk-Tech Inc), NDC00093-5061-01 (Teva Pharmaceuticals Usa, Inc.).
Key specifications for NDC10702-0011-01: Administration: ORAL; Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.